EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Differential Enteric Glial and Mast Cell Characteristics Distinguish Microscopic Colitis Subtypes Relative to Healthy and Disease Controls, with Treatment-Associated Reductions in Glial Reactivity and Mast Cell Degranulation in Collagenous Colitis

Julie Beaudeau iD, Celia Escudero-Hernández iD, Vittorio Abruzzese, Georgios Katinios iD, Gustav Orell iD, Nawroz Barazanji, Susanna Walter iD, Henrik Hjortswang, Vytautas Kiudelis, Juozas Kupčinskas iD, Andreas Münch, Åsa V Keita iD

Cells · 2026

DOI: 10.3390/cells15191778 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Julie Beaudeau und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Clinical Sciences, Linköping University, 58185 Linköping, Sweden. Hauptthemen laut MEDLINE: Mast Cells, Neuroglia, Cell Degranulation, Colitis, Collagenous. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stiftelsen Apotekare Hedbergs Fund for Medical Research, Linköping University, Ruth and Richard Julin Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microscopic colitis (MC) is an inflammatory bowel disease characterized by chronic watery diarrhea. Although barrier dysfunction and immune activation are implicated, underlying mechanisms remain unclear. The aim of this study was to characterize enteric glial cells (EGC) and mast cell distribution across MC subtypes, assess treatment effects, and explore EGC-related gene expression and barrier markers. Colonic biopsies from patients with active collagenous colitis (aCC), budesonide-refractory CC (rCC), and active lymphocytic colitis (LC) were compared to irritable bowel syndrome (IBS), ulcerative colitis (UC), and healthy controls (HC). A subset of CC patients was studied during active disease (aCC) and in clinical remission due to budesonide treatment (tCC). Immunofluorescence quantified EGC positive for glial fibrillary acidic protein (EGCGFAP+) and S100 calcium-binding protein B (EGCS100β+), mast cell tryptase, and tight junction proteins. RNA-sequencing assessed EGC-related gene expression. Results showed that EGCGFAP+ were highest in rCC and decreased following budesonide treatment in aCC, whereas EGCS100β+ were highest in aCC, remained unchanged following treatment, resembled IBS, and were reduced compared with UC. Mast cell numbers were higher in aCC than in HC and rCC but remained unchanged following treatment, while mast cell degranulation decreased after treatment. Tight junction proteins were unchanged. RNA-sequencing indicated differential regulation of EGC-related genes. In conclusion, MC shows subtype-specific alterations involving EGC and mast cells, suggesting distinct glial states and differential treatment responsiveness. Our findings support the presence of distinct neuroimmune alterations in CC and LC and highlight EGC as potential contributors to MC pathophysiology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mast CellsNeurogliaCell DegranulationColitis, CollagenousColitis, MicroscopicHumansFemaleMaleBudesonideMiddle AgedCase-Control StudiesAdult

Stichwörter der Autor:innen

RNA-sequencingbudesonidecollagenous colitisgastrointestinal pathophysiologyimmune cellsimmune regulationimmunofluorescenceinflammationlymphocytic colitisrefractory colitistight junctions

Substanzen

Budesonide

Autor:innen und Institutionen

  • Department of Biomedical and Clinical Sciences, Linköping University, 58185 Linköping, Sweden.
  • Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, 24105 Kiel, Germany.
  • Department of Paediatrics and Immunology, University of Valladolid, 47003 Valladolid, Spain.
  • Department of Gastroenterology and Hepatology, Linköping University Hospital, 58185 Linköping, Sweden.
  • Department of Health, Medicine and Caring Sciences, Linköping University, 58185 Linköping, Sweden.
  • Department of Gastroenterology, Institute for Digestive Research, Lithuanian University of Health Sciences, 50009 Kaunas, Lithuania.

ORCID-Profile: Julie Beaudeau, Celia Escudero-Hernández, Georgios Katinios, Gustav Orell, Susanna Walter, Juozas Kupčinskas, Åsa V Keita

Förderung

  • Stiftelsen Apotekare Hedbergs Fund for Medical Research
  • Linköping University
  • Ruth and Richard Julin Foundation
  • Medical Infection and Inflammation Center-MIIC
  • Research Council of Lithuania
  • European Crohn's and Colitis Organisation
  • Spanish Ministry of Science, Innovation and Universities
  • European Crohn’s and Colitis Organisation

Zitieren

APA

Beaudeau, J., Escudero-Hernández, C., Abruzzese, V., Katinios, G., Orell, G., Barazanji, N., Walter, S., Hjortswang, H., Kiudelis, V., Kupčinskas, J., Münch, A., & Keita, Å. V. (2026). Differential Enteric Glial and Mast Cell Characteristics Distinguish Microscopic Colitis Subtypes Relative to Healthy and Disease Controls, with Treatment-Associated Reductions in Glial Reactivity and Mast Cell Degranulation in Collagenous Colitis. Cells. https://doi.org/10.3390/cells15191778

Vancouver

Beaudeau J, Escudero-Hernández C, Abruzzese V, Katinios G, Orell G, Barazanji N, et al. Differential Enteric Glial and Mast Cell Characteristics Distinguish Microscopic Colitis Subtypes Relative to Healthy and Disease Controls, with Treatment-Associated Reductions in Glial Reactivity and Mast Cell Degranulation in Collagenous Colitis. Cells. 2026. doi:10.3390/cells15191778

BibTeX
@article{Beaudeau2026,
  author = {Beaudeau, Julie and Escudero-Hernández, Celia and Abruzzese, Vittorio and Katinios, Georgios and Orell, Gustav and Barazanji, Nawroz and Walter, Susanna and Hjortswang, Henrik and Kiudelis, Vytautas and Kupčinskas, Juozas and Münch, Andreas and Keita, Åsa V},
  title = {Differential Enteric Glial and Mast Cell Characteristics Distinguish Microscopic Colitis Subtypes Relative to Healthy and Disease Controls, with Treatment-Associated Reductions in Glial Reactivity and Mast Cell Degranulation in Collagenous Colitis},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15191778}
}
Kostenlos starten →